flychicken1991
Nov 4, 10:58 PM
$EVMN For
$20M upfront and warrants, Evommune (EVMN) licenses EVO570 with milestone payments possible. - Stock Titan. Impact: Negative (76%). Issuing 4,966,889 placement shares would dilute existing EVMN holders, while the
$20 million licensing payment consumes much of the planned
$30 million gross raise. Hinova's warrants add potential dilution or an additional cash claim... Source and what to watch next: https://nimpact.tech/newsimpact/news/3e97ade1291d6d30/evmn-for-20m-upfront-and-warrants-evommune-evmn-licenses-evo570-with-mil?utm_source=stocktwits&utm_medium=story_url
0 replies